RLY-2608
N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxo-2,3-dihydroisoindol-4-yl]-3-fluoro-5-(trifluoromethyl)benzamide
Molecular Identity
RLY-2608
N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxo-2,3-dihydroisoindol-4-yl]-3-fluoro-5-(trifluoromethyl)benzamide
PubChem CID: 166822065
2D Structure
Properties
C29H14ClF5N6O2
Molecular Formula
608.90
Molecular Weight
g/mol
608.0787
Exact Mass
Da
5.5
XLogP
Above Lipinski threshold
112
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
10
H-Bond Acceptors
1120
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
RLY-2608N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-1-oxo-2,3-dihydroisoindol-4-yl]-3-fluoro-5-(trifluoromethyl)benzamideN-((3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano-(1,2,4)triazolo(1,5-a)pyridin-6-yl)-1-oxo-2,3-dihydroisoindol-4-yl)-3-fluoro-5-(trifluoromethyl)benzamideRLY 2608RefChem:179562PI3Ka Inhibitor RLY-2608Pan-mutant PI3Ka Inhibitor RLY-2608Mutant-selective PI3Ka Inhibitor RLY-2608Pan-mutant PIK3CA-selective Inhibitor RLY-2608Pan-mutant-selective PI3K-alpha Inhibitor RLY-26082733573-94-7ZovegalisibRLY2608zovegalisib [INN]LR5XLA3BPC
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to RLY-2608
Loading drug network...